Skip to main content
. 2020 Aug 27;8(2):e001141. doi: 10.1136/jitc-2020-001141

Figure 3.

Figure 3

Waterfall plots of combination therapy while varying. (A) TMB; (B) PD-1 expression; (C) PD-L1 expression in cancer cells; (D) PD-L1 expression in APCs; (E) CEA expression; (F) CD3 expression in teff cells. APCs, antigen-presenting cells; CEA, carcinoembryonic antigen; PD1, programmed cell death protein 1; PD-L1, PD-ligand 1; TMB, tumor mutational burden.